Malignant spinal cord compression: NICE guidance, improvements and challenges.

Area of Science:

• Oncology
• Neurosurgery
• Clinical Medicine

Background:

• Malignant spinal cord compression (mSCC) is a severe cancer complication.
• NICE guidance aims to enhance mSCC patient pathways and outcomes.
• This study evaluates mSCC management post-NICE guidance implementation in West London.

Purpose of the Study:

• To examine current mSCC presentations.
• To analyze mSCC management strategies.
• To assess patient outcomes following NICE guidance.

Main Methods:

• Retrospective review of electronic records and clinical notes.
• Analysis of patient data from Charing Cross Hospital in 2012.
• Inclusion of referral numbers, confirmed mSCC proportion, cancer diagnosis, treatment, and outcomes.

Main Results:

• 191 patients reviewed; 127 (66%) had confirmed mSCC.
• Common cancers: prostate, lung, breast, and kidney.
• 21% presented with mSCC as their initial cancer diagnosis.
• Radiotherapy was primary treatment; 24% had initial surgery.
• 62% presented with severe mobility impairment (chair/bed-bound).
• 20% of severely impaired patients regained independent mobility post-treatment.

Conclusions:

• Improved patient pathways, rapid assessment, and prompt treatment enhance mSCC outcomes.
• Many patients still present with significant motor impairment.
• Over 20% of mSCC cases are diagnosed at presentation.
• Sustained awareness of mSCC diagnosis and emergency pathways is vital for primary care and patients.